Table 2.
SiO2 nanotoxicology
Type | Crystal phase | Size and characteristics | Animal or cell type | Concentration | Assay | Results | Reference |
---|---|---|---|---|---|---|---|
1 Mesoporous SiO2 | Amorphous |
|
Cancer cells (e.g. PANC-1, AsPC-1) |
|
In vitro bioassays
|
|
Lu et al. (2007b) |
2 Mesoporous and luminescent SiO2 |
Amorphous |
|
|
|
In vitro bioassays • MTT assay |
|
Chung et al. (2007) |
3 Multifunctional and luminescent SiO2 |
Amorphous |
|
Monocyte cell (bone marrow progenitor cells from C57BL/6 mice) |
|
In vitro bioassays • Cell viability assay |
• Non-toxic | Rieter et al. (2007a,b) |
4 Polymer and protein functionalized luminescent SiO2 |
Amorphous |
|
Jarkat T luekemia cell |
|
In vitro bioassays
|
|
Bottini et al. (2007) |
5 Organically modified SiO2 |
Amorphous |
|
Tumor cells (e.g. Colon-26, RIF-1) |
|
In vitro bioassays • Photosensitization assay |
|
Ohulchanskyy et al. (2007) |
6 Silicon nanowires | Silicon |
|
|
|
In vitro bioassays • Cell incubation |
• Murine stem cells survive for several days interfaced to silicon nanowires with 100 nm diameter |
Kim et al. (2007c) |
7 Synthetic SiO2 | Amorphous |
|
|
0.21–0.667 mg/mL for 2 days |
In vitro bioassays
|
|
Chang et al. (2007) |
8 Silica shell with quantum dot core |
|
• 15–20 nm overall size |
|
|
In vitro bioassays • Flow cytometry |
|
Zhelev et al. (2006) |
9 Multifunctional silica nanotubes |
Amorphous walls |
|
|
• 0.005, 0.05, 0.5, 5 μg/mL |
In vitro bioassays • MTT assay |
|
Son et al. (2006) |
10 Flame engineered SiO2 |
|
14 nm | Human mesothelioma rodent fibroblast cell lines (3T3) |
15 ppm for 6 days |
In vitro bioassays
|
Non-toxic | Brunner et al. (2006) |
11 N/A | Amorphous | 0.5–4 μm/1–12 μm | Human leukemic monocyte lymphoma (U937) used differentiated |
0.125–1 mg/well |
In vitro bioassays • LDH assay |
|
Yoshida et al. (2003) |
12
|
|
|
Human lung cancer cells (A549) |
|
In vitro bioassays
|
|
Lin et al. (2006a) |